Trending...
- How LIB's Temperature & Humidity Chamber & Walk-in Chamber Warranty Delivered Real Uptime
- CrownPoint Partners Brokers $1.05 Million Sale of Tuffy's Tire in Toledo, Ohio
- Summit Named to Columbus Business First's Fast 50 for the Fourth Time
Provides the Opportunity to Sell SafeBreak® Vascular in International Markets
FAYETTEVILLE, Ark. - OhioPen -- Lineus Medical has been granted Certificates of Registration for both EN IS0 13485:2016 and 13485:2016/MDSAP. These certify that the quality management system of Lineus Medical has been registered as conforming to high caliber, international standards. The certified quality management system applies to the design and development, manufacture, and distribution of SafeBreak Vascular.
The certifications were awarded based on passing a rigorous two stage audit conducted by Intertek, an international quality assurance and audit organization. The certificates allow Lineus Medical to enter into international markets with SafeBreak Vascular, the company's flagship product.
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer connector in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
More on Ohio Pen
"Obtaining these certifications is huge for the organization and is a testament to our high-Quality standards," Will Armstrong, COO of Lineus Medical stated. "We can now continue executing our strategic plan and expand into regions such as Japan, Korea, Canada, and Europe."
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally1. Peripheral IVs fail 46% of the time2 before their intended use is complete and cost the US healthcare system over $5B annually1.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
More on Ohio Pen
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015; 38(3): 189-203
The certifications were awarded based on passing a rigorous two stage audit conducted by Intertek, an international quality assurance and audit organization. The certificates allow Lineus Medical to enter into international markets with SafeBreak Vascular, the company's flagship product.
SafeBreak Vascular is a break-away connector that fits into any peripheral IV line on any standard luer connector in the world, although currently it is only cleared for use in the United States. The device is designed to separate when a damaging force is placed on an IV line, therefore reducing irritation of the vein and the chances of the IV dislodging. When the device separates, valves on each side of the device close to stop the flow of medication from the pump and blood flow from the patient's IV catheter. The separated SafeBreak can be replaced with a new, sterile SafeBreak and the IV restarted without the need for another needlestick for the patient. In a 2021 randomized controlled trial, SafeBreak Vascular was shown to reduce IV complications requiring an IV restart by 44%.1
More on Ohio Pen
- Blue Harvest Brands Acquires UltraClear®, Expanding Leadership in Natural Pond & Water Care
- LKPFM Corporation Special Bulletin 9/11 on Rx Processing Corp.com
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
"Obtaining these certifications is huge for the organization and is a testament to our high-Quality standards," Will Armstrong, COO of Lineus Medical stated. "We can now continue executing our strategic plan and expand into regions such as Japan, Korea, Canada, and Europe."
SafeBreak Vascular reduces the failure of peripheral IV lines and the negative cascade of events that occurs when an IV restart is required. Over 235M peripheral IVs are successfully placed in the United States each year and over 2B globally1. Peripheral IVs fail 46% of the time2 before their intended use is complete and cost the US healthcare system over $5B annually1.
ABOUT LINEUS MEDICAL
Lineus Medical is the developer of a patented, break-away technology designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and other medical tubing may be reduced with a device that breaks into two pieces to protect the patient's medical line. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn or Twitter.
More on Ohio Pen
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- Actor, Musician and Poker Player Nicholas Rascona to Take to ACR Poker Tables to Break Guinness World Record for Longest Marathon Playing Online Poker
- New Slotozilla Project Explores What Happens When the World Goes Silent
- The Two Faces of Charles D. Braun: How the Novel, Posthumously Yours, Came to Life
- "The Omniscient Buyer" Launches, Offering a Wake-Up Call for the AI Era of Sales and Marketing
1Data on file.
2Helm, R.E., et al., Accepted but Unacceptable: Peripheral IV Catheter Failure. Journal of Infusion Nursing. 2015; 38(3): 189-203
Source: Lineus Medical
0 Comments
Latest on Ohio Pen
- Fortune Media and Great Place To Work Name White Castle to 2025 Best Workplaces in Retail List, Ranking No. 18
- DivX Unveils New Educational Blog Series to Simplify MKV to MP4 Video Conversion
- Crimson Cup Congratulates 15 Independent Coffee Shops in 8 States Marking September Anniversaries
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Galaxy Service Partners Announces Partnership with Thomas Door
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- VidCliq Launches Faceless2Famous Project with AI Artist Truf as Podcast Host
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Wellness Coach Zakiyyah Broadnax Joins the Dear Black Woman Anthology
- Summit Named to Columbus Business First's Fast 50 for the Fourth Time
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
- NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets
- Wzzph Analyzes Crypto Market Maturation as Institutional Capital Drives $50B ETF Inflows